NeRRe Therapeutics raised €14M in a Series A round in Dec 2012. The company is based in Hertford, UK. Investors in the round: Advent Venture Partners, Novo A, S. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
